Clinical Trials Browser

Phase 2 × Completed × Nasopharyngeal Carcinoma × Clear all

NCT05563480 2026-04-07

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03267498 2026-01-12

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

40 enrolled 14 charts

Nasopharyngeal Carcinoma

NCT04227509 2025-12-31

Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04004871 2025-12-11

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT03984357 2025-07-17

PLATINUM

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04833257 2025-07-08

Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04736810 2025-03-07

A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03866967 2025-02-27

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

130 enrolled 3 FDA

Nasopharyngeal Carcinoma

NCT04996758 2024-12-12

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

Phase 2 Completed

Nasopharyngeal Carcinoma, Recurrence

NCT04895345 2024-09-26

A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04220307 2024-09-19

A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04396886 2024-05-09

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Phase 2 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT03025958 2024-05-06

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03558191 2024-03-15

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Phase 2 Completed

156 enrolled 13 charts

Nasopharyngeal Carcinoma

NCT05918224 2024-02-05

Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Stomatitis

NCT03906058 2023-10-25

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03848286 2023-10-23

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT00834093 2023-06-28

A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

Phase 2 Completed

18 enrolled 9 charts

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT04350190 2023-01-13

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04834206 2022-05-10

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT04508816 2022-04-04

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT02562599 2022-02-22

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT02237924 2022-02-14

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT02605967 2022-02-10

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

122 enrolled 28 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Recurrence, Disorders of Sex Development

NCT00592501 2021-10-26

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Phase 2 Completed

25 enrolled 16 charts

Nasopharyngeal Carcinoma

NCT05020067 2021-08-25

Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03668366 2021-02-11

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT01187238 2020-07-16

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03389295 2019-12-16

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT02339558 2019-09-13

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Phase 2 Completed

45 enrolled 12 charts

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01309633 2019-07-22

Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT03839602 2019-02-15

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03283293 2019-02-12

Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT01392235 2019-01-22

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT01621880 2019-01-09

BRAIN

Phase 2 Completed

112 enrolled 10 charts

Nasopharyngeal Carcinoma, Radiation Injuries

NCT02269943 2018-12-12

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

36 enrolled 24 charts

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT02309437 2018-07-17

Early Use of Opioid in Radiation Mucositis

Phase 2 Completed

Nasopharyngeal Carcinoma, Nutrition Disorders, Pain

NCT02776124 2018-03-19

Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT03427359 2018-02-09

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT00953420 2017-08-18

CADEN

Phase 2 Completed

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT01326559 2017-08-16

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT01370070 2017-01-13

MC1079

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT02360501 2016-04-20

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01616849 2015-09-22

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT00565448 2015-07-30

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Phase 2 Completed

75 enrolled 10 charts

Nasopharyngeal Carcinoma, Carcinoma, Nasopharyngeal Neoplasms

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT00815087 2014-03-26

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

20 enrolled 6 charts

Nasopharyngeal Carcinoma, Deglutition Disorders

NCT01865201 2013-12-12

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT01271439 2013-08-13

REPLACE

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT00700440 2010-03-26

ENCORE

Phase 2 Completed

100 enrolled 4 charts

Nasopharyngeal Carcinoma